Pharmaceutical Marketing
The side effects of Pharmaceutical companies taking the Social Media pill
By Amraj Lalli
Here is a short [corrected] advertisement for PRISTIQ, an antidepressant made by Pfizer:
Pharmaceutical Advertisement spending peaked in 2006, when $5.41 billion dollars were spent on ads; over 50% of the spending was on television ads, while only 5% was for internet display ads. The next few years saw a drop in spending on advertising, while many medical companies began to test the waters with social media. Companies like WebMD, Johnson & Johnson, and Pfizer created YouTube channels, Twitter pages, Facebook pages, and engaged in two-way conversations with consumers. Although some pharmaceutical companies already have their social media connections, many have yet to connect with the dynamic, growing, and interactive communities that are offered in social media.
Through this presentation, I question why pharmaceutical companies have been so reluctant to engage in social media, the risks and benefits of using social media, and how they are going to effectively join the social media revolution.
Pharmaceutical Companies in Social Media from Amraj Lalli
Sources:
The U.S. Food and Drug Administration
The Huffington Post: Pharmaceutical Companies and Promotional Spending
PharmaPhorum.com: Social Media in the Pharmaceutical Industry 2012
Pfizer in Social Media
Accenture Newsroom
PRISTIQ Labeling, by Pfizer
Sources:
The U.S. Food and Drug Administration
The Huffington Post: Pharmaceutical Companies and Promotional Spending
PharmaPhorum.com: Social Media in the Pharmaceutical Industry 2012
Pfizer in Social Media
Accenture Newsroom
PRISTIQ Labeling, by Pfizer
No comments:
Post a Comment